Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma

  • Rafael Fúnez1Email author,

    Affiliated with

    • Teresa Pereda1,

      Affiliated with

      • Isabel Rodrigo1,

        Affiliated with

        • Luis Robles1 and

          Affiliated with

          • Carlos González1

            Affiliated with

            Diagnostic Pathology20072:30

            DOI: 10.1186/1746-1596-2-30

            Received: 04 May 2007

            Accepted: 21 August 2007

            Published: 21 August 2007

            Abstract

            Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the kidney with clinicopathologic peculiarities that seems to be of better prognosis than conventional renal cell carcinoma. Classical and eosinophilic types are the two histological variants recorded. Also, it has been described in association with carcinoma of collecting ducts, conventional renal cell carcinoma and sarcomatoid renal cell carcinoma. Squamous renal carcinoma is a very rare neoplasm with a malignant course. We describe a case of simultaneous chromophobe renal cell carcinoma with squamous cell carcinoma, finding which, to the best of our knowledge, has not previously been reported.

            Background

            Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the kidney described by Thoenes et al. in 1986 with clinicopathologic peculiarities, composed of typical cells with iron colloidal positive stain and seems to be of better prognostic than conventional renal cell carcinoma [1]. Classical and eosinophilic types are the two histological variants recorded. Also, it has been described in association with carcinoma of collecting ducts, conventional renal cell carcinoma and sarcomatoid renal cell carcinoma. We describe a case of concomitant chromophobe renal cell carcinoma and squamous cell carcinoma of the kidney.

            Case report

            The patient, a 68-year-old hypertensive female presented with total hematuria and right flank pain. The ultrasonogragraphy demonstrated a solid mass with probably calcificated areas and cystic changes, and the CT scan a tumour in the upper pole of the kidney with heterogeneous contrast caption, calcifications and no enlargement of lymph nodes.

            Grossly the kidney showed a tumor centred in the upper pole with 4.6 cms in greatest dimension, without perinephric tissues or renal vein invasion. The neoplasm was in part brown and homogenous with other area grey coloured with necrotic/haemorrhagic appearance and calcifications. There was not presence of renal calculi in the renal pelvis. There was relationship of the neoplasm to the renal pelvis focally (figure 1). Also a normal macroscopically adrenal gland and two lymph nodes were received.
            http://static-content.springer.com/image/art%3A10.1186%2F1746-1596-2-30/MediaObjects/13000_2007_Article_76_Fig1_HTML.jpg
            Figure 1

            Macroscopical aspect of the neoplasm. Squamous cell carcinoma (sq) and Chromophobe renal cell carcinoma (chr).

            Microscopically the tumour was composed by a typical chromophobe renal cell carcinoma with positive Hale's colloidal iron stain and negative inmmunocytochemistry test for vimentin (Dakocytomation S.A.) in the areas with brown, homogeneous appearance (figure 2). Near by these areas there was another zone with necrosis, extensive calcification and solid epithelial nests with some keratin pearls and obvious squamous differentiation (figures 3, 4). These cells were negative for Hale's colloidal iron stain and positive for cytokeratin 5/6 (Dakocytomation S.A.). Sections from the area where both tumors were in contact did not show a collission effect (figure 5). There were focal relationship between both tumors and renal pelvis. We studied carefully the urinary tract to devoid an urothelial neoplasm and did not found signs of chronic tract infection or squamous metaplasia suggestive of irritation of pelvic or calyceal epithelium. The tumour did not invade perinephric tissues, adrenal gland or lymph nodes. The patient is alive without metastasis or recurrence after 32 months.
            http://static-content.springer.com/image/art%3A10.1186%2F1746-1596-2-30/MediaObjects/13000_2007_Article_76_Fig2_HTML.jpg
            Figure 2

            Areas with typical chromophobe renal cell carcinoma. HE × 200.

            http://static-content.springer.com/image/art%3A10.1186%2F1746-1596-2-30/MediaObjects/13000_2007_Article_76_Fig3_HTML.jpg
            Figure 3

            Zone with squamous cell carcinoma. HE × 200.

            http://static-content.springer.com/image/art%3A10.1186%2F1746-1596-2-30/MediaObjects/13000_2007_Article_76_Fig4_HTML.jpg
            Figure 4

            Zone with squamous cell carcinoma. HE × 400.

            http://static-content.springer.com/image/art%3A10.1186%2F1746-1596-2-30/MediaObjects/13000_2007_Article_76_Fig5_HTML.jpg
            Figure 5

            Border region of two tumors. There was not collission effect. HE × 100.

            Discussion

            Transitional cell carcinoma constitutes the majority of the renal pelvis and calyces tumors. Squamous cell carcinoma accounts about 1% of renal neoplasms. A few cases of concomitant renal cell carcinoma and transitional cell carcinoma have been reported [24]. The simultaneous occurrence of renal cell carcinoma and squamous cell carcinoma is excepcional. The first case was reported by Elsa Valderrama et al in 1987. Subsequently, Charles et al described the association of renal squamous carcinoma and cystic renal cell carcinoma [3] and renal pelvis squamous cell carcinoma with renal cell carcinoma in a tuberculous kidney [4]. Likewise has been reported association of renal cell carcinoma with another renal cell neoplasms (conventional renal cell carcinoma, oncocytoma, collecting duct carcinoma) and cases with sarcomatoid transformation [5, 6] or extensive calcification with ossification [7]. More recently also has been described one case with focal papillary growth pattern, basaloid features of the nuclear arrangement and stromal osseous metaplasia containing fatty bone marrow elements [8].

            The histogenesis of the renal squamous carcinoma is controversial [2, 9]. It is associated with renal pelvis calculi frequently, and continuos irritation of the transitional epithelium could produce metaplastic squamous changes and subsequently malignant transformation. CHRC is consistently positive for parvalbumin and calcium-binding protein expressed in the distal nephron, a feature further suggesting a histogenetic relationship between this tumor and the intercalated ducts [10]. Simultaneous chromophobe renal cell carcinoma and squamous renal carcinoma could present some questions. Perhaps, the most interesting of them is if the neoplasm is a CHRC with a concomitant squamous carcinoma derived from a transitional neoplasm, that seems more plausible, or if it is a squamous differentiation in a CHRC. It has to be said that the macroscopic appearance favor a unique motley neoplasm and the carefully study of the urinary tract did not show any urothelial neoplasm, urothelial displastic areas or any reason to justify irritation of the transitional epithelium. Curiously, Valderrama et al. did not found any of them in their case either [2]. Moreover, the squamous neoplasm were situated in a area with necrosis and extensive calcification, that could represent an strange form of differentiation later an event of tumoral necrosis. Anyway, this case it be either two concomitant different neoplasm or a differentiation in a CHRC, is a finding that has not previously been reported to the best of our knowledge.

            Declarations

            Acknowledgements

            we thank to Dr. Ferran Algaba Arrea from Fundacio Puigvert, Barcelona, Spain, who reviewed this case for his helpful suggestions.

            Authors’ Affiliations

            (1)
            Department of Pathology, Hospital Costa del Sol

            References

            1. Crotty TB, Farrow GM, Liber MM: Chromophobe cell renal cell carcinoma, clinicopathological features of 50 cases. J Urol 1995, 154:964–967.View ArticlePubMed
            2. Valderrama E, Kalra J, Badlani G, Kahn BK: Simultaneous renal cell carcinoma and squamos cell carcinoma of kidney. Urology 1987,39(4):441–445.View Article
            3. Charles RS, Wein AJ, Wilczynski s, Tomaszewski JE, Hanno PM: Cystic renal cell and squamous cell carcinoma of single kidney with concurrent transitional cell carcinoma of ipsilateral ureter and urinary bladder. Urology 1992,39(5):470–472.View ArticlePubMed
            4. Al-Assiri M, Al-Otabi MF, Sicar K, Laplante M: Renal pelvis squamous cell carcinoma in a tuberculous kidney. The Scientific World Journal 2004, 4:965–968.
            5. Ging Y, Sun X, Haines K, Pins MR: Renal cell carcinoma, chromophobe type, with collecting duct carcinoma and sarcomatoid components. Arch Pathol Lab Med 2003, 127:38–40.
            6. Itoh T, Chikai K, Ota S, Nakagawa T, Takiyama A, Mouri G, Shinohara N, Yamashita T, Suzuki S, Koyanagi T, Nagashima K: Chromophobe renal cell carcinoma with osteosarcoma-like differentiation. Am J Surg Pathol 2002,26(10):1358–62.View ArticlePubMed
            7. Wu SL, Fishman IJ, Shannon RL: Chromophobe renal cel carcinoma with extensive calcification and ossification. Ann Diagn Pathol 2002, 6:244–7.View ArticlePubMed
            8. Kuroda N, Iiyama T, Moriki T, Shuin T, Enzan H: Chromophobe renal cell carcinoma with focal papillary configuration, nuclear basaloid arrangement and stromal osseous metaplasia containing fatty bone marrow element. Histopathology 2005,46(6):712–713.View ArticlePubMed
            9. Maganto E, Escudero A, Sanchez J, Lopez F, Martinez-Pineiro JA: Carcinoma escamoso de la pelvis renal. Rev Clin Esp 1977, 146:103.
            10. Martignoni G, Pea M, Chilosi M, Brunelli M, Scarpa A, Colato C, Tardanico R, Zamboni G, Bonetti F: Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 2001, 14:760–767.View ArticlePubMed

            Copyright

            © Fúnez et al. 2007

            This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

            Advertisement